Overview

Implementation of initiatives aimed at curbing unwanted pregnancies associated healthcare expenditure and the subsequent growth in user awareness levels are expected to drive the contraceptives industry over the forecast period.

According to the U.S. Centers for Disease Control and Prevention, approximately 37% of the birth in the U.S. is a result of unwanted pregnancy, a proportion which has remained stagnant since 1982. Despite advancements in technology and the amount spent every year on R&D, U.S. unplanned pregnancy rate has remained unchanged for decades. The U.S. federal policy has taken measures to increase contraceptive availability by mandating its coverage by health insurance companies and permitting the Emergency Contraceptives (ECs) to be available Over-The-Counter (OTC). The presence of an extensive product pipeline portfolio is expected to boost industry growth.